Compare ARK Genomic Revolution ETF (ARKG) vs AT&T Inc. (T) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs AT&T Inc. — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while AT&T Inc. trades at $21.2 (market cap $146.82B). The key difference: AT&T Inc. pays a 5.25% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, AT&T Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | T | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $29.62 |
52-Week Low | $23.09 | $20.49 |
Market Cap | — | $146.82B |
Enterprise Value | — | $292.17B |
Dividend Yield | — | 5.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
AT&T (T) trades at $21.13, up 0.48% today but near 52-week lows, with a bearish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 7.11, net income margin of 16.94%, and three consecutive quarterly EPS beats. Recent news highlights SpaceX competition concerns, though the company maintains robust cash flow and a 5.3% dividend yield.
The outlook is mixed: valuation appears attractive with analyst consensus target of $26.43 (25% upside), but technical weakness and competitive threats pose risks. Investment opportunity lies in income generation and potential rebound if execution continues, while key risks include debt levels and industry disruption from new entrants.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
